BRPI0925100A2 - forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica - Google Patents

forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica

Info

Publication number
BRPI0925100A2
BRPI0925100A2 BRPI0925100A BRPI0925100A BRPI0925100A2 BR PI0925100 A2 BRPI0925100 A2 BR PI0925100A2 BR PI0925100 A BRPI0925100 A BR PI0925100A BR PI0925100 A BRPI0925100 A BR PI0925100A BR PI0925100 A2 BRPI0925100 A2 BR PI0925100A2
Authority
BR
Brazil
Prior art keywords
dosage form
osmotic dosage
preparing
osmotic
dosage
Prior art date
Application number
BRPI0925100A
Other languages
English (en)
Inventor
Alan Ka Chun Chan
Chunliu Zhu
Dayu Zhai
Gan Yong
Robert L Schmitt
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Publication of BRPI0925100A2 publication Critical patent/BRPI0925100A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
BRPI0925100A 2009-06-02 2009-06-02 forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica BRPI0925100A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2009/072099 WO2010139111A1 (en) 2009-06-02 2009-06-02 Sustained release dosage form

Publications (1)

Publication Number Publication Date
BRPI0925100A2 true BRPI0925100A2 (pt) 2016-07-19

Family

ID=43297260

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0925100A BRPI0925100A2 (pt) 2009-06-02 2009-06-02 forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica

Country Status (7)

Country Link
US (1) US8956654B2 (pt)
EP (1) EP2437733A4 (pt)
JP (1) JP2012528799A (pt)
KR (1) KR20140069381A (pt)
CN (1) CN102573811A (pt)
BR (1) BRPI0925100A2 (pt)
WO (1) WO2010139111A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2691982T3 (es) * 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
US10053597B2 (en) 2013-01-18 2018-08-21 Basf Se Acrylic dispersion-based coating compositions
US20160022571A1 (en) * 2013-03-14 2016-01-28 Braeburn Pharmaceuticals Bvba Sprl Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof
CA2932290C (en) * 2013-12-06 2023-06-13 Durect Corporation Compositions comprising antioxidant, fluid dispensers, and methods involving the same
WO2017040607A1 (en) * 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
JP2017160327A (ja) * 2016-03-09 2017-09-14 信越化学工業株式会社 揮発性組成物
CN108201536A (zh) * 2016-12-16 2018-06-26 中国科学院上海药物研究所 一种奥拉帕尼口服缓控释药物组合物及其用途
WO2018232413A1 (en) * 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
ES2861153T3 (es) * 2018-06-18 2021-10-05 Composiciones de liberación prolongada que comprenden piridostigmina
DK3628004T3 (da) * 2018-06-27 2021-12-20 Amneal Complex Products Res Llc Selvregulerende osmotiske mave-tarm tilbageholdende leveringssystemer til lægemiddel
US20220241184A1 (en) * 2019-06-21 2022-08-04 Kashiv Biosciences, Llc Gastroretentive dosage forms of levodopa and carbidopa

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4034758A (en) 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5021053A (en) 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
CA2685214C (en) * 2001-02-08 2013-01-22 Andrx Pharmaceuticals, Inc. Improved controlled release oral dosage form
CN1371680A (zh) 2001-12-07 2002-10-02 沈阳药科大学 青藤碱渗透泵型控释制剂及其制备方法
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
WO2006046114A2 (en) 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Osmotic dosage forms providing ascending drug release, and processes for their preparation
US20080213381A1 (en) * 2005-03-14 2008-09-04 Pharmaceutical Industries Limited Oral Drug Delivery System
US7884136B2 (en) * 2005-06-27 2011-02-08 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
CN100584319C (zh) * 2006-10-16 2010-01-27 北京科信必成医药科技发展有限公司 群孔释放渗透泵控释片及其制备方法
US20090004281A1 (en) 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
BRPI0908114A2 (pt) * 2008-02-15 2015-10-06 Sun Pharma Advanced Res Co Ltd tabuleta oral de liberação controlada

Also Published As

Publication number Publication date
EP2437733A4 (en) 2014-01-08
US8956654B2 (en) 2015-02-17
US20120045485A1 (en) 2012-02-23
KR20140069381A (ko) 2014-06-10
EP2437733A1 (en) 2012-04-11
CN102573811A (zh) 2012-07-11
JP2012528799A (ja) 2012-11-15
WO2010139111A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
BRPI0925100A2 (pt) forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BR112012001874A2 (pt) estrutura composita sobremoldada e processo para fabricar uma estrutura composita sobremoldada
BRPI1010766A2 (pt) processo para rebaudiosídeo d
BR112012015322A2 (pt) propante e método para formar o propante
ES2829950T8 (es) Procedimiento para producir componentes endurecidos
BRPI1011743A2 (pt) processo para preparar poliéster insaturado
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI1013561A2 (pt) Processo para a preparação de alogliptina
BR112012002102A2 (pt) composição farmaceutica e metodo para preparar uma composição farmaceutica
BRPI1014911A2 (pt) processo para fabricação de resinas carregadas
BRPI1012528A2 (pt) aparelho para depósito
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BR112013016365A2 (pt) composição de lipossoma e processo para produção do mesmo
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BR112013012873A2 (pt) processo para preparar uma n, n-dialquiletanolamina
BRPI1007211A2 (pt) composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição.
BR112014006454A2 (pt) composição degeladora , e, processo para produzir uma composição degeladora
BRPI0923574A2 (pt) processo para a preparação de uma forma em pó de peptídeo
BR112012000258A2 (pt) processo para preparar uma alquenona.
BR112013014949A2 (pt) processo para produção de proteína
BR112013005986A2 (pt) processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo
BR112012001731A2 (pt) Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol
BR112012014011A2 (pt) mistura compatibilizada, artigo e método para preparar uma mistura compatibilizada

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.